Corydalis is a flowering plant with tuberous roots that has been used in Traditional Chinese Medicine for over 1,100 years, primarily as a natural pain reliever. The species most commonly found in supplements is Corydalis yanhusuo, and its roots contain a group of alkaloids that interact with pain signaling pathways in the body. It’s sold in the U.S. as a dietary supplement, not an approved medication, and is most often marketed for pain, sleep, and anxiety.
The Plant and Its History
Corydalis belongs to the poppy family (Papaveraceae) and includes hundreds of species, many with showy spurred flowers that give them ornamental appeal. The medicinally important species grow tuberous roots, and it’s these tubers that get harvested, dried, and processed into extracts. Corydalis yanhusuo and Corydalis decumbens are the two most prominent species listed in the Pharmacopoeia of China, while several related species appear in the Japanese and Korean pharmacopoeias.
The plant was first documented in a Chinese pharmaceutical text dating to the Northern and Southern Dynasties period (roughly 618 to 907 AD). For centuries, practitioners prescribed it to improve blood circulation, relieve pain associated with blood stasis, and address what Traditional Chinese Medicine calls Qi stagnation. Chest pain was one of its primary traditional uses.
How It Works in the Body
Corydalis root contains dozens of alkaloids, but three stand out for their pain-relieving properties. The first, levo-tetrahydropalmatine (l-THP), has been approved by the Chinese government since 1964 for human use in chronic pain, insomnia, and anxiety. It works partly by blocking dopamine receptors, which is unusual for a pain-relieving compound and distinguishes it from opioid-based painkillers. The second, dehydrocorybulbine (DHCB), targets both inflammatory and nerve injury pain through similar receptor pathways. The third, dehydrocorydaline (DHC), has shown effects on pain associated with bone cancer in animal studies.
What makes the whole extract interesting is that it appears to address multiple types of pain simultaneously. Animal studies have shown that Corydalis yanhusuo extract reduces responses to acute heat pain, chemically triggered inflammatory pain, and nerve injury pain, all at doses that don’t cause sedation. Perhaps most notably, the extract did not produce tolerance in these studies, meaning repeated use didn’t require higher doses to achieve the same effect. That’s a significant contrast to opioid painkillers, where tolerance develops quickly.
Pain Relief Across Multiple Types
The research on Corydalis covers a surprisingly broad range of pain models, though nearly all of it comes from animal studies rather than large human clinical trials. Individual compounds from the plant have shown activity against inflammatory pain, neuropathic pain (caused by nerve damage), and visceral pain (the deep, cramping kind associated with organ systems). Two compounds, corydine and corydaline, reduced writhing behavior in mice by 51% and 59% respectively. Berberine, another alkaloid present in the root, reduced neuropathic pain in a dose-dependent manner. Palmatine, yet another component, showed promise specifically for diabetic nerve pain.
L-THP has been tested in human contexts, though mostly in China. It demonstrated effects on both neuropathic and inflammatory chronic pain without producing motor impairment, which is a common side effect of many conventional pain medications.
Sleep and Anxiety Effects
Beyond pain, Corydalis has a reputation as a mild sedative. L-THP produces noticeable sedation at higher doses (above roughly 100 mg for a person weighing about 70 kg), which is why some sleep supplements include Corydalis as an active ingredient. In one clinical study, l-THP significantly reduced insomnia severity compared to placebo. Its effects on mood, however, were not statistically significant in that same trial, suggesting it may help more with the physical restlessness of sleeplessness than with the emotional component.
Typical Dosage
In traditional practice, the raw dried tuber is taken at about 5 to 10 grams per day. L-THP makes up roughly 0.2% of the dried plant material by weight, so that traditional dose delivers a relatively small amount of the most studied compound. Concentrated extracts sold as supplements vary widely in potency, and there’s no universally standardized dose. Clinical research has used l-THP at 60 mg twice daily in human subjects. If you’re considering a supplement, the concentration of active alkaloids matters far more than the total weight of plant material listed on the label.
Safety Concerns and Liver Risk
Corydalis is not without risk. A growing number of case reports link it to drug-induced liver injury. In one published case, a 52-year-old man with no prior health conditions developed dark urine, fatigue, nausea, and vomiting after taking a corydalis-containing sleep supplement. He had used it only occasionally, about once per month for a year, with more frequent use in the weeks before his symptoms appeared. His liver function improved after he stopped taking the supplement.
In another case, a patient developed jaundice and abdominal pain with a cholestatic pattern, meaning bile flow from the liver was disrupted. His condition improved, then returned when he resumed taking a corydalis product. L-THP specifically has been implicated in liver toxicity through its presence in another Chinese herbal product called Jin Bu Huan, which was associated with multiple cases of hepatitis in the 1990s. Rechallenge studies, where patients unknowingly took the product again, confirmed that corydalis-containing tablets caused elevations in multiple liver enzymes.
These cases don’t mean everyone who takes corydalis will experience liver problems, but they establish that it can be hepatotoxic in some individuals. The risk appears higher with repeated or escalating use.
Drug Interactions
Corydalis contains berberine, a compound that alters how the liver metabolizes certain medications. This can change the effectiveness or side effects of drugs broken down by the same liver pathways. Specific concerns include diabetes medications, since berberine can lower blood sugar on its own, creating a risk of dangerously low levels when combined with insulin or oral diabetes drugs. It may also interact with immunosuppressants like cyclosporine by changing how quickly the body clears them.
Because berberine can prolong bleeding time and slow nervous system activity, the general recommendation is to stop taking corydalis at least two weeks before any scheduled surgery.
Regulatory Status in the U.S.
Corydalis is sold legally in the United States as a dietary supplement, not as an approved drug. The FDA does not evaluate supplements for effectiveness before they reach store shelves. When companies market corydalis-containing products with claims about treating or preventing specific diseases, the FDA has taken enforcement action. In a December 2023 warning letter, the agency cited a supplement company for marketing products containing corydalis with claims about pain relief and circulation, stating these claims made the products unapproved drugs under federal law.
The FDA also noted that supplement labels must use the standardized name “Corydalis yanhusuo” rather than just “Corydalis” to properly identify the ingredient. This is a small detail, but it reflects the broader issue with herbal supplements: labeling standards are inconsistent, and what’s actually in the bottle can vary significantly between brands. If you’re buying a corydalis product, look for one that specifies the species, the part of the plant used (tuber or root), and ideally the concentration of key alkaloids.